26.9137 USD
-0.08 (-0.28%)
Last: Jan 9, 2023, 08:23 PM
Overall MTBCP gets a fundamental rating of 3 out of 10. We evaluated MTBCP against 35 industry peers in the Health Care Technology industry. The financial health of MTBCP is average, but there are quite some concerns on its profitability. While showing a medium growth rate, MTBCP is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- In the past year MTBCP has reported negative net income.
- MTBCP had a positive operating cash flow in the past year.
1.2 Ratios
- The profitability ratios for MTBCP are negative, so there is not much use analyzing them.
- With an excellent Return On Invested Capital value of 4.81%, MTBCP belongs to the best of the industry, outperforming 84.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | 4.81% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- MTBCP has a Operating Margin of 3.77%. This is in the better half of the industry: MTBCP outperforms 73.33% of its industry peers.
- MTBCP has a Gross Margin of 38.04%. This is in the lower half of the industry: MTBCP underperforms 66.67% of its industry peers.
- MTBCP's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.77% | ||
| PM (TTM) | N/A | ||
| GM | 38.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-3.59%
2. Health
2.1 Basic Checks
- MTBCP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for MTBCP has been increased compared to 1 year ago.
- The debt/assets ratio for MTBCP is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 9.66 indicates that MTBCP is not in any danger for bankruptcy at the moment.
- With an excellent Altman-Z score value of 9.66, MTBCP belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
- The Debt to FCF ratio of MTBCP is 0.06, which is an excellent value as it means it would take MTBCP, only 0.06 years of fcf income to pay off all of its debts.
- MTBCP has a Debt to FCF ratio of 0.06. This is amongst the best in the industry. MTBCP outperforms 82.22% of its industry peers.
- MTBCP has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
- MTBCP has a better Debt to Equity ratio (0.00) than 64.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.06 | ||
| Altman-Z | 9.66 |
ROIC/WACC0.6
WACC8.03%
2.3 Liquidity
- MTBCP has a Current Ratio of 1.21. This is a normal value and indicates that MTBCP is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of MTBCP (1.21) is worse than 73.33% of its industry peers.
- MTBCP has a Quick Ratio of 1.19. This is a normal value and indicates that MTBCP is financially healthy and should not expect problems in meeting its short term obligations.
- With a Quick ratio value of 1.19, MTBCP is not doing good in the industry: 71.11% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 56.73% over the past year.
- Looking at the last year, MTBCP shows a small growth in Revenue. The Revenue has grown by 7.14% in the last year.
- The Revenue has been growing by 41.63% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)56.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)7.14%
Revenue growth 3Y40.35%
Revenue growth 5Y41.63%
Sales Q2Q%-11.96%
3.2 Future
- Based on estimates for the next years, MTBCP will show a small growth in Earnings Per Share. The EPS will grow by 6.25% on average per year.
- MTBCP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.57% yearly.
EPS Next Y13.69%
EPS Next 2Y7.89%
EPS Next 3Y16.8%
EPS Next 5Y6.25%
Revenue Next Year0.64%
Revenue Next 2Y1.19%
Revenue Next 3Y3.72%
Revenue Next 5Y2.57%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for MTBCP. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MTBCP. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, MTBCP is valued cheaper than 84.44% of the companies in the same industry.
- MTBCP's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MTBCP is cheaper than 71.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 46.5 | ||
| EV/EBITDA | 23.41 |
4.3 Compensation for Growth
- MTBCP's earnings are expected to grow with 16.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.89%
EPS Next 3Y16.8%
5. Dividend
5.1 Amount
- No dividends for MTBCP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:MTBCP (1/9/2023, 8:23:58 PM)
26.9137
-0.08 (-0.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-03 2022-11-03/bmo
Earnings (Next)03-13 2023-03-13
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap409.63M
Revenue(TTM)143.75M
Net Income(TTM)-6.85M
Analysts83.64
Price Target76.1 (182.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-220.54%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.24%
Min EPS beat(2)4.61%
Max EPS beat(2)61.87%
EPS beat(4)4
Avg EPS beat(4)48.06%
Min EPS beat(4)4.61%
Max EPS beat(4)94.23%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.73%
Min Revenue beat(2)-3.14%
Max Revenue beat(2)-2.32%
Revenue beat(4)1
Avg Revenue beat(4)-1.01%
Min Revenue beat(4)-3.14%
Max Revenue beat(4)2.51%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.43%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.85 | ||
| P/FCF | 46.5 | ||
| P/OCF | 19.3 | ||
| P/B | 3.98 | ||
| P/tB | 34.48 | ||
| EV/EBITDA | 23.41 |
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)0.58
FCFY2.15%
OCF(TTM)1.39
OCFY5.18%
SpS9.44
BVpS6.76
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | 4.81% | ||
| ROICexc | 4.99% | ||
| ROICexgc | 43.34% | ||
| OM | 3.77% | ||
| PM (TTM) | N/A | ||
| GM | 38.04% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-3.59%
F-Score4
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.06 | ||
| Debt/EBITDA | 0.03 | ||
| Cap/Depr | 103.98% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 9.66 |
F-Score4
WACC8.03%
ROIC/WACC0.6
Cap/Depr(3y)81.08%
Cap/Depr(5y)58.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y13.69%
EPS Next 2Y7.89%
EPS Next 3Y16.8%
EPS Next 5Y6.25%
Revenue 1Y (TTM)7.14%
Revenue growth 3Y40.35%
Revenue growth 5Y41.63%
Sales Q2Q%-11.96%
Revenue Next Year0.64%
Revenue Next 2Y1.19%
Revenue Next 3Y3.72%
Revenue Next 5Y2.57%
EBIT growth 1Y261.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1308.1%
EBIT Next 3Y177.57%
EBIT Next 5Y93.09%
FCF growth 1Y213.67%
FCF growth 3Y-21.74%
FCF growth 5YN/A
OCF growth 1Y1553.9%
OCF growth 3Y25.1%
OCF growth 5YN/A
CARECLOUD INC - MTBC 11 PERP / MTBCP FAQ
What is the ChartMill fundamental rating of CARECLOUD INC - MTBC 11 PERP (MTBCP) stock?
ChartMill assigns a fundamental rating of 3 / 10 to MTBCP.
Can you provide the valuation status for CARECLOUD INC - MTBC 11 PERP?
ChartMill assigns a valuation rating of 1 / 10 to CARECLOUD INC - MTBC 11 PERP (MTBCP). This can be considered as Overvalued.
Can you provide the profitability details for CARECLOUD INC - MTBC 11 PERP?
CARECLOUD INC - MTBC 11 PERP (MTBCP) has a profitability rating of 1 / 10.
What is the expected EPS growth for CARECLOUD INC - MTBC 11 PERP (MTBCP) stock?
The Earnings per Share (EPS) of CARECLOUD INC - MTBC 11 PERP (MTBCP) is expected to grow by 13.69% in the next year.